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Abstract: Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the west-
ward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination
of raccoon RV from the eastern USA has proven challenging across targeted raccoon (Procyon lotor)
and striped skunk (Mephitis mephitis) populations impacted by raccoon RV. Field trial evaluations
of the Ontario Rabies Vaccine Bait (ONRAB) were initiated to expand ORV products available to
meet the rabies management goal of raccoon RV elimination. This study describes the continuation
of a 2011 trial in West Virginia. Our objective was to evaluate raccoon and skunk response to ORV
occurring in West Virginia for an additional two years (2012–2013) at 75 baits/km2 followed by
three years (2014–2016) of evaluation at 300 baits/km2. We measured the change in rabies virus-
neutralizing antibody (RVNA) seroprevalence in targeted wildlife populations by comparing levels
pre- and post-ORV during each year of study. The increase in bait density from 75/km2 to 300/km2
corresponded to an increase in average post-ORV seroprevalence for raccoon and skunk populations.
Raccoon population RVNA levels increased from 53% (300/565, 95% CI: 50–57%) to 82.0% (596/727,
95% CI: 79–85%) during this study, and skunk population RVNA levels increased from 11% (8/72,
95% CI: 6–20%) to 39% (51/130, 95% CI: 31–48%). The RVNA seroprevalence pre-ORV demonstrated
an increasing trend across study years for both bait densities and species, indicating that multiple
years of ORV may be necessary to achieve and maintain RVNA seroprevalence in target wildlife
populations for the control and elimination of raccoon RV in the eastern USA.
Keywords: bait density; ONRAB; oral rabies vaccination; rabies virus; raccoon; skunk; virus-
neutralizing antibody
1. Introduction
Oral rabies vaccination (ORV) is a proven prevention and control method for large-
scale landscape applications targeting rabies viruses (RV) circulating in wildlife [1]. ORV
has been successfully used to eliminate the canine RV variant in coyotes (Canis latrans) in
south Texas, USA [2,3] and RV in red foxes (Vulpes vulpes) and raccoon dogs (Nyctereutes
procyonoides) across Europe [4]. The use of ORV targeting red foxes and striped skunks
(Mephitis mephitis) eliminated the arctic fox (Vulpes lagopus) RV from large areas in southern
Ontario, Canada [5,6]. However, related viruses have re-emerged in red foxes and striped
skunks in southwestern Ontario, requiring new management activities for arctic fox RV
control [7]. Strategies focused on ORV have proven effective across species and geographic
areas and have prevented the westward spread of raccoon RV from the eastern USA.
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Rabies was first reported in raccoons (Procyon lotor) in Florida during the 1940s [8].
Raccoon RV spread from Florida north into South Carolina and west into Alabama during
the 1960s and 1970s [9]. An unintentional translocation of infected raccoons in 1977 from
Florida to West Virginia resulted in a RV epizootic that rapidly spread along the USA
eastern seaboard [10,11] and raccoon RV remains enzootic throughout the eastern seaboard
of the USA [12]; consequently, much of this region faces higher disease prevention costs due
to higher risks of rabies exposure from raccoons, skunks and other animals infected with
raccoon RV [13–15]. During 1998, the United States Department of Agriculture, Animal and
Plant Health Inspection Service, Wildlife Services, National Rabies Management Program
(NRMP) received its first Congressional appropriation to prevent terrestrial RV spread [16]
and established the national goal to eliminate specific wildlife RVs in the USA. Critical to
any wildlife RV elimination effort is achieving adequate population immunity to reduce
the susceptible fraction of hosts and prevent RV transmission among reservoir populations.
Meso-carnivore wildlife reservoirs implicated in the routine spillover of RV can leverage a
strong impact on the success of control efforts, e.g., the expanded ORV management focus
across Europe formalized in 2015 to include raccoon dogs as targeted vectors of red fox
RV [17]. ORV campaigns in the USA have varied in effectiveness as measured by post-bait
RV neutralizing antibody (RVNA) seroprevalence [15,18], yet estimates have also been
developed to estimate prevalence reduction among target populations [19,20].
Prior to 2011, the only vaccine available for use in the USA was RABORAL V-RG®
(Boehringer Ingelheim [formerly Merial, Inc.], Duluth, GA, USA), which has been used
to control RV in coyotes and raccoons and also used experimentally to target gray foxes
(Urocyon cinereoargenteus) and striped skunks [21]. The RVNA seroprevalence achieved us-
ing RABORAL V-RG has averaged 30% among orally vaccinated raccoon populations [22],
and is estimated to be lower (3–7%) among orally vaccinated skunk populations in the
eastern USA [15,18]. With a goal of raccoon RV elimination, the NRMP has an interest
to evaluate and refine ORV products and strategies for striped skunks, which are key
spillover hosts of raccoon RV [23,24]. Skunks have a history of being spillover hosts to
heterologous wildlife RV, as occurred in Arizona with a bat RV [25] and arctic fox RV in
southeastern Ontario [6]. Moreover, there is concern that raccoon RV may persist in striped
skunk populations and compromise local raccoon RV elimination success in areas of the
eastern USA [23,24].
The Ontario Rabies Vaccine Bait (ONRAB, Artemis Technologies, Inc. Guelph, On-
tario, Canada) has been a prospective ORV tool for raccoon RV elimination based on
post-distribution RVNA seroprevalence levels observed in raccoon and striped skunk
populations in Canada and the USA [5,26–29]. The ONRAB bait contains the vaccine in a
blister pack coated with a sweet bait matrix containing 100 mg of the biomarker tetracycline
hydrochloride (TTCC; see Graham and Prevec [30], Rosatte et al. [31]). During 2011, the
first ONRAB field trial in the USA occurred in an ORV-naïve area with enzootic raccoon
RV in southeastern West Virginia. That application resulted in one of the highest RVNA
seroprevalence levels among raccoons after ORV baiting in an ORV-naïve area of the eastern
USA [32]. We discuss the results from a continued evaluation in West Virginia for two
consecutive years (2012–2013) at a density of 75 baits/km2 followed by three consecutive
years (2014–2016) of ORV using ONRAB at 300 baits/km2. Our objective was to evaluate
the impact of ORV using standard and high-density baiting methods by measuring and
comparing the RVNA responses among targeted raccoon and striped skunk populations in
a rural area of West Virginia.
2. Materials and Methods
2.1. Study Area and Design
The 2012–2013 ONRAB field trial was conducted in West Virginia, USA (37 47′ N,
80 37′ W) as a continuation of a study initiated during 2011 [32]. Raccoon and striped skunk
marking and sampling occurred within four 127 km2 cells established during 2011 that were
separated by 5 km buffers and located to minimize edge effects around areas where target
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wildlife were sampled. Study cells were located in Monroe, Summers, and Greenbrier
Counties and consisted mainly of forest and agriculture habitat (Figure 1). The ONRAB
baits were distributed at 75/km2 with 750 m parallel flight lines or by ground means
(hand distribution from vehicles) throughout this area similar to 2011 (see Slate et al. [32]).
During the period 2014–2016, we reduced pre- and post-ORV sampling to three of the four
original cells. Target bait density was quadrupled to 300/km2 and flight-line spacing was
reduced to 250 m, similar to ORV strategies reported by Rosatte et al. [5].
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which were 65% forested, 28% agriculture, 6% developed, 1% water and <1% barren. For 
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We grouped habitat into five categories based on the National Land Cover Database
(NCLD)—agriculture (values 71, 81, 82), forested (values 41, 42, 43, 52), developed (values
21, 22, 23, 24), water (values 11, 90, 95), and barren (value 31) and habitat composition
was based on the 2011 NCLD [33] for the four cells sampled during the period 2012–2013,
hich ere 65 forested, 28 agriculture, 6 developed, 1 ater and <1 barren. For
the three cells sa pled during the period 2014–2016, the habitat composition was based on
the 2016 NLCD [34] and the cells were 63% forested, 30% agriculture, 7% developed, 1%
water and <1% other.
2.2. Animal Sampling
A random point system was used to guide trap placement of 150 traps within cells,
as described by Slate et al. [32] and Gilbert et al. [28]. Trapping occurred during July and
August prior to ORV and during October post-ORV (Table 1). Methods for generating
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points were the same as described by Gilbert et al. [28]. The same points were used for the
two trapping periods within each year and new points were generated each consecutive
year. For a single cell, each pre- and post-ORV trapping period consisted of 10 consecutive
nights. During 2014 and 2015, skunk-focused trapping was used to complement the
random location trapping efforts to increase sample sizes. Skunk-focused trapping was
accomplished by trapping on cell properties with a history of skunk presence based on
landowner reports and past trapping experience. The number of trap nights for enhanced
skunk trapping varied based on capture success on the properties, which ranged from 1 to
44 traps per night. Skunk-focused trapping during 2014 occurred for 17 days and 13 days
in the pre- and post-ORV periods, respectively, and during 2015 for 12 days and 13 days
in the pre- and post-ORV periods, respectively. This study was conducted in compliance
with the National Wildlife Research Center (NWRC) Institutional Care and Use Committee
(IACUC) guidelines (protocols QA-1905, 2028, and 2313). The skunk focused trapping
in the period 2014–2015 occurred under the approval of the NWRC IACUC. Standard
live-trapping and sampling were IACUC deferred due to the activities described being
considered as routine management.
Table 1. Trapping dates for pre- and post-oral rabies vaccination (ORV) by year and Ontario Rabies
Vaccine Bait (ONRAB) density in West Virginia, USA.
Year Period Trapping Dates Bait Density (Baits/km2)
2012 Pre-ORV 17 July–10 August 2012 75
Post-ORV 3–13 October 2012 75
2013 Pre-ORV 16 July–9 August 2013 75
Post-ORV 22 October–1 November 2013 75
2014 Pre-ORV 17 July–3 August 2014 300
Post-ORV 6–19 October 2014 300
2015 Pre-ORV 21 July–1 August 2015 300
Post-ORV 5–17 October 2015 300
2016 Pre-ORV 19–29 July 2016 300
Post-ORV 11–21 October 2016 300
All live trapping occurred using cage traps (Tomahawk Live Trap, LLC, Hazelhurst,
WI, USA). Animals with abnormal behavior or suspect lesions were euthanized and tested
by a direct rapid immunohistochemistry test (dRIT) [35]. The dRIT positives were sent
to the Centers for Disease Control and Prevention (CDC) for diagnostic confirmation
and RV variant typing. Captured and apparently healthy target species (i.e., raccoons,
striped skunks, red foxes, gray foxes, and coyotes) were anesthetized using a 5:1 mixture
of ketamine:xylazine for body measurements and sample collection, whereas nontarget
animals were immediately released from traps at the location of capture. For each target
animal, we determined sex, relative age (adult or juvenile), and weight (kg); we collected
a blood sample from a peripheral vein, extracted a first premolar tooth, and applied an
unique numbered ear tag to both ears (National Band and Tag Company, Newport, KY,
USA). Target species were processed once per trapping period, but individuals were re-
processed when recaptured during a subsequent trapping period. Healthy appearing target
animals were released at the point of capture after recovery from anesthesia. On the day of
capture, serum samples were separated from whole blood by centrifugation and aliquots
were stored in labeled cryovials at −25 to −70 ◦C until analysis.
2.3. RVNA Determination
Sera were analyzed using a modified neutralization test [36] by the New York State Depart-
ment of Health (NYSDOH). Similar to Gilbert et al. [28], we report main results using a cutoff
of 0.125 IU/mL to identify RVNA seropositive animals. We also present results using a higher
0.5 IU/mL cutoff (Supplementary Files, Figures S1 and S3, Tables S4, S5, S11, S13 and S15–S19).
Samples with RVNA values less than the cutoff were considered seronegative.
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A subset of samples was independently analyzed using a standard rapid fluorescent
focus inhibition test [37] at Kansas State University. The subset consisted of 300 raccoon sera
and 39 skunk sera that tested within the range of 0.125–0.5 IU/mL at NYSDOH (Table S1).
2.4. Tetracycline Biomarker and Age Determination
Teeth were processed for TTCC deposition and age class at Matson’s Laboratory
(Manhattan, Montana, USA). Levels of TTCC deposition were determined with a Leitz
compound microscope (Leica Microsystems GmbH, Wetzlar, Germany) using ultraviolet
light at 100×magnification. Records from 626 (21%) raccoons and 86 (30%) skunks were
missing TTCC results due to either a poor-quality tooth sample or no tooth sample available.
Age determination was made by cementum annuli counts [38]. In the field, relative age
for juvenile (<1 year) and adult (≥1 year) was assessed from animal body size, weight,
and reproductive status [39]. A specific year age class assignment was not possible for 659
(22%) raccoon and 98 (34%) skunk records due to either a poor-quality tooth sample or no
tooth sample available.
2.5. Statistical Methods
We used a generalized linear mixed model (GLMM) implemented in program R [40]
to compare seroprevalence responses in raccoon or skunk populations under the ORV
conditions applied, which include bait density (75/km2 or 300/km2), duration of baiting in
years (at a specific density), and sampling period (pre- or post-ORV). We also investigated
the interaction between baiting duration and sampling period, to account for trends over
time pre-ORV compared to post-ORV. Seroprevalence was modeled with a beta distribu-
tion which ranges between zero and one (betareg) [41]. We treated study cell as a random
effect term to account for spatial covariance structure in the response data from popu-
lations sampled. We repeated this analysis using TTCC results as the response variable
(Supplementary File, Figure S8 and Table S10). We also conducted a model selection on
seroprevalence to compare the weights and ranks in fit to the study data (Supplementary
File and Tables S11–S15).
We used generalized additive modeling (GAM) to examine seroprevalence at the individ-
ual animal level. Analysis occurred using the package mgcv (v 1.8-28) [42]. Raccoon and skunk
analyses were conducted separately and the same set of models were compared within each
species using Akaike’s information criterion corrected (AICc) for small sample sizes [43]. We
tested the same models (Table S2) using three different binary response variables: RVNA at the
0.125 IU/mL cutoff, RVNA at the 0.5 IU/mL cutoff (Supplementary File and Tables S16–S19),
and binary TTCC detection (Supplementary File and Tables S20–S23). Our predictor variables
were animal age (years), sex (male or female), period (pre- or post-ORV), bait density (75/km2
or 300/km2), and baiting duration in years. Year and study cell were treated as random effects.
For sex, we coded females as 0, males as 1 and those missing data as 0.5. We used yearly age
classes based on cementum annuli counts when available. If an animal was recaptured in a
different trapping period and missing cementum age data, we used a previous known age to
estimate that animal’s age class for that trapping period. For individuals that had only relative
age classifying them as a juvenile (<1 year), age class was listed as zero. For adult raccoons and
skunks with unknown age class, we coded the records as 2.35 years for raccoons and 1.46 years
for skunks, which was the mean of the negative binomial distribution fit to the adult age data
for each species. Competitive models were considered as having a change of ≤ 2 in AICc from
the top model.
3. Results
Cumulatively over the five-year study period, 1,506,678 baits were distributed by
either air or ground means (Table 2). During the period 2012–2013, when the target bait
density was 75/km2, an average of 132,339 (±479 SD) baits were distributed/year. During
the period 2014–2016, when the target bait density was 300/km2, an average of 414,000
(±4124 SD) baits were distributed/year. We processed sera for RVNA from 3256 carnivores
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sampled during the period 2012–2016. Raccoons accounted for 90.8% (n = 2955) of animals
captured, followed by striped skunks (8.9%; n = 290). Red foxes, gray foxes, and coyotes
represented less than 1.0% of captures. Raccoons and skunks were recaptured during
619 and 50 events, respectively, and all events were included in total count of captures
per species. During this study, 20 target animals were euthanized, one was found dead
(i.e., roadkill), and four died under care; 64% (16/25) of the animals were tested for rabies.
Two striped skunks tested positive with the raccoon RV variant during 2013, whereas
14 other animals tested negative for rabies during the period 2012–2015. The two positive
skunks were euthanized for abnormal behavior and the presence of a lesion. During 2016,
no study animals were submitted for testing.
Higher RVNA seroprevalence was observed in raccoon and skunk populations sam-
pled across the high-density (300/km2) ORV during the period 2014–2016 (Figure 2,
Table S3). For reference in 2011, the area was naïve for ORV prior to the baiting that
year; the published pre-ORV seroprevalence was 9.6% (38/395, 95% CI: 7.1–12.9%) among
raccoons and 5% (1/20, 95% CI: 1–24%) among skunk populations and post-ORV sero-
prevalence that year was 49.2% (129/262, 95% CI 43.2–55.3) for raccoons and 7% (2/28,
95% CI 2–23%) for skunks [32]. Average pre-ORV seroprevalence in the study area at the
0.125 IU/mL cutoff for the two years (2012–2013) at 75 baits/km2 was 46.6% (362/776,
95% CI: 43.2–50.2%) for raccoon and 15% (4/27, 95% CI: 6–32%) for skunk populations.
Average post-ORV seroprevalence during standard density (75 baits/km2) ORV during the
period 2012–2013 was 53.1% (300/565, 95% CI: 50.0–57.2%) among raccoon and 11% (8/72,
95% CI: 6–20%) among skunk populations. In 2014, baiting transitioned to 300 baits/km2;
pre-ORV seroprevalence was 46.9% (130/277, 95% CI 41.1–52.8) for raccoon and 10%
(3/30, 95% CI 4–26%) for skunk populations and post-ORV seroprevalence that year was
79.5% (147/185, 95% CI 73.1–84.7) for raccoons and 46% (22/48, 95% CI 33–60%) for
skunks. Average pre-ORV seroprevalence for the two years (2015–2016) following the
initial 300 baits/km2 distribution in 2014 was 84.4% (514/609, 95% CI: 81.3–87.1%) for
raccoon and 29% (9/31, 95% CI: 16–47%) for skunk populations. Average post-ORV sero-
prevalence at the high-density ORV during the period 2015–2016 was 82.7% (449/543,
95% CI: 79.3–85.6%) for raccoon and 35% (29/82, 95% CI: 26–48%) for skunk populations.
At the higher cutoff of 0.5 IU/mL, we re-examined seroprevalence estimates for raccoon
and skunk samples and continued to observe a higher seroprevalence for both raccoons
and skunks at the 300 baits/km2 compared to 75 baits/km2 treatment (Figure S1, Table S4).
A higher proportion of raccoons and skunks were marked with TTCC at 300 baits/km2
than at 75 baits/km2 (Figure S2).
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Table 2. Number of Ontario Rabies Vaccine Baits (ONRAB) distributed and overall area covered during oral rabies vaccination by aerial or ground distribution methods at target bait




Ground Dates Total Baits Total Area (km2)
Targeted Bait Density
Year Baits Area (km2) Baits Area (km2) (Baits/km2)
2012 131,154 2343 26 August 2012 1524 27 28 August 2012 132,678 2370 75
2013 130,476 2300 3 September 2013 1524 27 27 August 2013 132,000 2327 75
2014 412,200 1864 26–28 August 2014 6300 27 27 August 2014 418,500 1891 300
2015 404,100 1864 26–27 August 2015 6300 27 27 August 2015 410,400 1891 300
2016 406,800 1864 30 August–2 September 2016 6300 27 31 August 2016 413,100 1891 300
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Figure 2. skunk (b) rabies virus-neutralizing antibody (RVNA) seroprevalence
from oral rabies vac ination (ORV) field trials with Ontario Rabies Vac ine Baits (ONRAB) in West
Virginia, USA in relationship to bait density, sampling period (pre- or post-ORV), and year. RVNA
cutoff observed was 0.125 IU/mL for the period 2012–2016. * Information from 2011 was from
Slate et. al. [32] and included for comparison with years 2012–2016.
The population-level GLMM indicated positive relationships between bait density and
levels of RVNA among raccoon and skunk populations at the 0.125 IU/mL cutoff (Table 3).
Among raccoon populations, the estimated seroprevalence increased post-ORV from 53%
(95% CI: 49–56%) using 75 baits/km2 to 83% (95% CI: 81–85%) using 300 baits/km2.
Seroprevalence pre-ORV increased over time for both bait densities, whereas there was
no apparent trend for increasing seroprevalence post-ORV within the period 2012–2013 or
the period 2014–2016, respectively (Figure S3). Among skunk populations, the estimated
seroprevalence increased post-ORV from 16% (95% CI: 15–16%) at 75 baits/km2 to 38%
(95% CI: 36–39%) at 300 baits/km2. The duration of baiting increased seroprevalence
pre-ORV for both bait densities, but this trend was not observed post-ORV (Figure S3).
Similar trends for the GLMM were observed among raccoon population pre- and post-
ORV and among skunk populations pre-ORV when modeling the seroprevalence response
data at the 0.5 IU/mL cutoff (Table S5, Figure S3). Model selection supported bait density
as a key factor influencing raccoon and skunk population seroprevalence (Supplementary
File and Tables S11–S15).
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Table 3. Covariate estimates for generalized linear mixed model on raccoon and skunk seroprevalence from oral rabies
vaccination (ORV) at the 0.125 IU/mL cutoff in West Virginia, USA.
Species Parameter Estimate Std. Error z Value Pr (>|z|)
Raccoons Intercept −2.75 0.40 −6.81 0
Bait density 0.01 0.00 9.10 0
Years of baiting 0.88 0.15 6.01 0
Period (pre- or post-ORV) 2.23 0.49 4.58 0
Years of baiting X period −0.83 0.21 −4.01 0
Skunks Intercept −3.96 0.83 −4.79 0.00
Bait density 0.01 0.00 3.71 0.00
Years of baiting 0.66 0.28 2.35 0.02
Period (pre- or post-ORV) 1.71 0.91 1.88 0.06
Years of baiting X period −0.60 0.38 −1.56 0.12
For the individual-level GAM at the 0.125 IU/mL cutoff, the raccoon dataset yielded
one competitive model (Table S6) and skunk dataset had six competitive models (Table S7).
The raccoon top model contained two-way interactions of period x age and bait density
x years of baiting, in addition to the main effect terms and sex (Table S8). This model
had a marginalized and conditional R2 of 0.270. Older raccoons were more likely to be
seropositive, especially during the post-ORV period (Figure 3). Raccoons captured during
ORV using 300 baits/km2 were also more likely to be seropositive with multiple years of
baiting also increasing the probability of being seropositive. Male raccoons were more likely
to be seropositive than females regardless of a slightly higher proportion of females positive
at the 75 baits/km2 post-ORV (Figure 4). The top skunk model contained the main effects of
period, bait density, and years of baiting (Table S9) and had a marginalized and conditional
R2 of 0.136. Skunks captured during 300 baits/km2 ORV, during a post-ORV period, or
following more years of baiting were more likely to be seropositive. Age (Figure S4) and sex
(Figure S5) were not in the top skunk model, but sex was in a competitive model (Table S9).
All six of the competing models contained the main effects of bait density and period.
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4. Discussion 
The standard ORV bait density used to target raccoons in the USA is 75 baits/km2. 
However, it has been recognized since the early years of ORV in the USA that there was 
no compelling scientific basis for a constant bait density of 75 baits/km2 across all raccoon 
populations in the eastern USA and the NRMP has reported use of 150 baits/km2 to target 
raccoon populations in urban or higher risk areas (e.g., Selma, AL [44]; St. Lawrence River, 
NY [45]; Pinellas County, FL [46]; Vermont-Quebec border [27]). Early testing regarding 
the population-level response to ORV using target bait densities of 75, 150, and 300/km2 
in Ohio showed higher seroprevalence among raccoons as RABORAL V-RG bait density 
increased [47]. In spite of this positive early response to ORV in Ohio, the magnitude of 
the population seroprevalence response did not meet the theoretical vaccination coverage 
(≥60%) recommended for effective raccoon RV control and elimination [48,49]. Pedersen 
et al. [50] reported a similar trend for RABORAL V-RG in a Pennsylvania field trial with 
target bait densities approximating those evaluated by Sattler et al. [47], yet a subsequent 
study at 75/km2 and 150/km2 in Virginia indicated no change in seroprevalence between 
treated target populations [51]. 
The initial 2011 ONRAB field trial in the USA resulted in a 49.2% raccoon seropreva-
lence post-ORV, the highest observed for an initial baiting at 75 baits/km2 in an ORV-na-
ïve, raccoon RV enzootic area [32]. The post-ORV seroprevalence during the period 2012–
2013 remained similar for raccoons at 53.1%. While raccoon cases were in decline by 2013 
in the study area, skunk cases were still being detected during 2013 and the field trial was 
continued during the period 2014–2016, but with a greater target bait density of 300/km2 
in view of the encouraging response observed by Rosatte et al. [5] targeting control of 
arctic fox RV in skunks in southern Ontario. Our high-density ORV did result in higher 
RVNA seroprevalence in raccoons and skunks, regardless of IU/mL cutoff level applied. 
The highest level of seroprevalence we observed post-ORV was 83.1% for raccoons and 
60% for skunks and both occurred during the final year of this field trial (Figure 2). 
Our results can be compared to the ONRAB field evaluation that occurred at 75 
baits/km2 in the northeastern USA (rural northeastern NY and northern VT and NH) [28] 
and in the St. Lawrence region of NY [29]. For raccoon populations baited annually at 75 
baits/km2 and evaluated for RVNA seroprevalence using the same serologic methods, 
West Virginia and the St. Lawrence region had comparable average post-seroprevalence, 
which was 53.1% (95% CI 50.0–57.2%) and 55.9% (95% CI 53.1–60.8%) [29], respectively, 
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Figure 4. Proportion of raccoons seropositive for rabies virus-neutralizing antibodies (RVNA) at a cutoff of 0.125 IU/mL by
sex and bait densities sampled pre- and post-oral rabies vaccination (ORV) in West Virginia, USA. Error bars represent 95%
confidence intervals.
4. Discussion
The standard ORV bait density used to target raccoons in the USA is 75 baits/km2.
However, it has been recognized since the e rly year of ORV in the USA that there was no
compelling scientific basis for a constant bait density of 75 baits/km2 across all raccoon
populations in the eastern USA and the NRMP has reported use of 150 baits/km2 to target
raccoon populations in urban or higher risk areas (e.g., Selma, AL [44]; St. Lawrence
River, NY [45]; Pinellas County, FL [46]; Vermont-Quebec border [27]). Early testing re-
garding the population-level response to ORV using target bait densities of 75, 150, and
300/km2 in Ohio show d higher seropr valence among raccoons as RABORAL V-RG bait
density increased [47]. In spite of this positive early response to ORV in Ohio, the magni-
tude of the population seroprevalence response did not meet the theoretical vaccination
coverage (≥60%) recommended for effective raccoon RV control and elimination [48,49].
Pedersen et al. [50] reported a similar trend for RABORAL V-RG in a Pennsylvania field
trial with target bait de sities appr xi ating those valuated by Sattler et al. [47], yet a sub-
sequent study at 75/km2 and 150/km2 in Virginia indicated no change in seroprevalence
between treated target populations [51].
The initial 2011 ONRAB field trial in the USA resulted in a 49.2% raccoon seropreva-
lence post-ORV, the highest observed for an initial baiting at 75 baits/km2 in an ORV-naïve,
raccoon RV enzootic area [32]. The post-ORV seroprevalence during the period 2012–2013
remained similar for raccoons at 53.1%. While raccoon cases were in decline by 2013 in
the study area, skunk cases were still being detected during 2013 and the field trial was
continued during the period 2014–2016, but with a greater target bait density of 300/km2
in view of the encouraging response observed by Rosatte et al. [5] targeting control of arctic
fox RV in skunks in southern Ontario. Our high-density ORV did result in higher RVNA
seroprevalen e in raccoons and skunks, regardless of IU/mL cutoff level applied. The
highest level of seroprevalence we observed post-ORV was 83.1% for raccoons and 60% for
skunks and both occurred during the final year of this field trial (Figure 2).
Our results can be compared to the ONRAB field evaluation that occurred at 75 baits/km2
in the northeastern USA (rural northeastern NY and northern VT and NH) [28] and in the St.
Lawrence region of NY [29]. For raccoon populations baited annually at 75 baits/km2 and
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evaluated for RVNA seroprevalence using the same serologic methods, West Virginia and
the St. Lawrence region had comparable average post-seroprevalence, which was 53.1%
(95% CI 50.0–57.2%) and 55.9% (95% CI 53.1–60.8%) [29], respectively, while the post-ORV
seroprevalence was 68.5% (95% CI 66.2–70.8%) for the northeastern USA field trial site [28],
commensurate with enhanced progress in regional raccoon RV elimination [20]. Any
factor that influences bait uptake and seroprevalence may have contributed to differences
among locations. Possible factors that may negatively influence bait uptake are increased
non-target bait competition, higher raccoon densities, smaller home ranges, and higher
availability of anthropogenic food resources [52–54].
Age was a factor related to seroprevalence in West Virginia, the St. Lawrence region
and northeastern USA, as well as southern Quebec, Canada [55]. This consistent result
across studies and regions suggests that the level of seroprevalence estimated can depend
on both the recruitment rate of juveniles into the adult population and survival of previ-
ously vaccinated animals. We observed a saturating effect in RVNA seroconversion among
raccoons for both bait density applications and following successive years of ORV, which
had been an expectation from the early report regarding the first year of evaluation in West
Virginia [32]. Other studies have observed a similar trend with targeted raccoon popula-
tions [28,47,55]. Even when seroprevalence may increase with years of baiting, population
turnover can diminish seroprevalence gains within a few years once management activities
cease. Over 85% of the raccoons sampled were ≤3 years of age in this study (Figure S6)
and in Gilbert et al. [28]; both observed a serologic asymptote after two years of baiting.
Thus for raccoons, continued baiting past two or three years without modifying the baiting
strategy may be unlikely to result in further increases in RVNA seroprevalence.
For skunks captured during ONRAB field trials in the USA, the average post-ORV
RVNA response at 75 baits/km2 was similar among the different regions at 18% (95%
CI 13–26%), 19% (95% CI 13–27%), and 11% (95% CI 6–20%) for the northeastern USA,
St. Lawrence region, and West Virginia, respectively. Also observed among these stud-
ies was the occasional year where the measured pre-ORV seroprevalence among skunks
appeared higher than post-ORV seroprevalence in that same year (e.g., 2014 in north-
eastern USA, 2014 in St. Lawrence region, and 2013 in West Virginia). In all of these
years, the actual number of seropositive skunks post-ORV was the same or higher than
the number seropositive skunks pre-ORV, but the total captures post-ORV was greater
than the pre-ORV period indicating that at least some of the variability in seroprevalence
estimates is likely influenced by overall and seasonal capture success. Given that rac-
coons were the focal target of these ORV field trials and their evaluation, factors such
as sex and age that may have influenced skunk seroprevalence were not examined and
thus, were not available for comparison. In southern Quebec, skunk age, sex, weighted
bait density, habitat type, and number of ONRAB ORV campaigns at 43–155 baits/km2
were evaluated, but none of these variables explained the variation observed in skunk
population seropositivity [55]. We found that skunks sampled at 300 baits/km2, post-
ORV, or in later years of baiting were more likely to be seropositive at the lower RVNA
threshold cutoff employed. We also observed that older age, greater bait density and
increased years of baiting were associated with RVNA seroconversion at the higher RVNA
threshold cutoff (of 0.5 IU/mL). We examined two different assay cutoffs since the lower
RVNA is relevant to raccoon rabies management in the USA [56] and the higher cut-
off is relevant for comparisons with wildlife rabies management in other countries (e.g.,
Canada). The Supplementary File, Figures S1 and S3, Tables S4, S5, S11, S13 and S15–S19
provides additional results and discussion at the 0.5 IU/mL cutoff. Given that 99% of
the skunks we sampled were ≤3 years of age (Figure S7), we might expect a more rapid
population turnover cycle with striped skunks compared to raccoons.
Estimates of RVNA seroprevalence and rabies case reduction are two key metrics
used by the NRMP for monitoring ORV and related activities (e.g., trap-vaccinate-release).
RVNA seroprevalence is a correlate of survival among orally vaccinated target wildlife
against lethal rabies virus infection [57] even when the presence of the some RVNA (e.g.,
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detection in a pre-ORV period in a ORV-naïve area) may be due to natural sublethal RV
exposures [8,58,59]. Just as there is no specific ORV bait density to uniformly apply to all
target populations, there is not one level of seroprevalence needed to eliminate raccoon RV
in all places. Theoretical estimates of population immunity for elimination range from 50%
to 100% for foxes [60–62], are similar for raccoons [48,63,64], and are underdeveloped for
skunk populations. This variation in the vaccination coverage necessary for elimination
may be due to population density, movement patterns, contact rates and enzootic versus
epizootic phases of transmission [48,65–67] as well as other potential factors such as the
size and scale of landscapes and populations under consideration. RVNA seroprevalence
measured for the raccoon population in WV at both bait densities (53% at 75 baits/km2 and
82% at 300 baits/km2) is within the theoretical estimates for rabies control and elimination.
The other key metric for evaluating ORV success is case reduction confirmed through
enhanced rabies surveillance [68]. Occasionally, a natural reduction in incidence can occur
without management intervention or management intervention may not be the only cause
for case reduction [69,70]. Our study area prior to 2011 was enzootic for raccoon RV with
detection of ≥10 raccoon RV cases annually (Table 4). Cases in raccoons were no longer
detected after 2011, but raccoon RV continued to be detected from skunks during the period
2012–2014. After one year of ONRAB distribution at 300 baits/km2, no further cases of
raccoon RV were detected. Furthermore, raccoon RV cases in any species have not been
detected in years following this study (through 2019). The timing of the ORV management
interventions used in this study are associated with locally observed case reductions.
Table 4. Raccoon rabies virus variant surveillance from 2008 to 2019 in the area of the Ontario Rabies
Vaccine Bait (ONRAB) trials in West Virginia, USA. Data are a combination of direct fluorescent
antibody testing performed by the West Virginia Department of Health and Human Resources
(WVDHHR; data used with permission) and direct rapid immunohistochemistry testing performed
by the United States Department of Agriculture, Wildlife Services.
Year Negatives Positives Rabid Raccoons Rabid Skunks Rabid Others 1
2008 33 10 3 5 2
2009 75 33 23 8 2
2010 113 31 13 15 3
2011 81 34 14 19 1
2012 88 3 0 3 0
2013 47 9 0 9 0
2014 54 2 0 2 0
2015 59 0 0 0 0
2016 32 0 0 0 0
2017 30 0 0 0 0
2018 2 19 0 0 0 0
2019 56 0 0 0 0
1 Other rabid animals with the raccoon rabies virus variant included one fox and one goat in 2018; one sheep and
one woodchuck in 2009; one dog, one fox and one gray fox in 2010; and one cat in 2011. 2 Missing WVDHHR-
negative data.
5. Conclusions
Increasing ONRAB bait density from 75/km2 to 300/km2 resulted in robust RVNA
seroprevalence among raccoons and skunks sampled. Rabies cases in the study area
declined to zero across multiple years of application but the risk for re-infection with
raccoon RV could return after a few years post-management and depends on spatial
landscape context and the ecology and connectivity of reservoir populations. The higher-
density baiting treatment is prohibitively costly over large landscapes for the control and
prevention of raccoon RV, but may be strategically employed for elimination in high-risk
areas including areas with elevated risk of spillover to wildlife and domesticated animals.
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Supplementary Materials: The following are available online at https://www.mdpi.com/1999
-4915/13/2/157/s1, Files: Expanded results on (1) tetracycline (TTCC) biomarker observed, (2)
generalized liner mixed modeling (GLMM) for rabies virus-neutralizing antibodies (RVNA) at
0.5 IU/mL cutoff, for TTCC, and for model selection, and (3) generalized additive modeling (GAM)
for RVNA at 0.5 IU/mL cutoff and TTCC biomarker. Figure S1: Raccoon (a) and skunk (b) rabies
virus-neutralizing antibody (RVNA) seroprevalence from oral rabies vaccination (ORV) field trials
with Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA in relationship to bait density,
sampling period (pre- or post-ORV), year. RVNA cutoff observed was 0.5 IU/mL). Error bars reflect
the 95% confidence interval. Figure S2: Proportion of (a) raccoons and (b) skunks positive for
tetracycline hydrochloride (TTCC) biomarker from the oral rabies vaccination (ORV) field trials with
Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA in relationship to bait density, sampling
period (pre- or post-ORV), and year. A total of 2,329 samples from raccoons and 204 samples from
skunks were evaluated. Error bars reflect the 95% confidence interval. Figure S3: Estimated raccoon
and skunk rabies virus-neutralizing antibody (RVNA) seroprevalence from oral rabies vaccination
(ORV) field trials with Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA in relationship
to bait density, sampling period (pre- or post-ORV), and year. Estimates were from a beta regression
analysis using RVNA cutoffs at 0.125 IU/mL (a: raccoons and b: skunks) and at 0.5 IU/mL (c:
raccoons and d: skunks). Shading represents the 95% confidence interval. Figure S4: Proportion
of skunks seropositive for rabies virus-neutralizing antibodies (RVNA) at a cutoff of 0.125 IU/mL
by age and bait densities sampled pre- and post-oral rabies vaccination (ORV) in West Virginia,
USA. Error bars represent 95% confidence intervals. Figure S5: Proportion of skunks seropositive
for rabies virus-neutralizing antibodies (RVNA) at a cutoff of 0.125 IU/mL by sex and bait densities
sampled pre- and post-oral rabies vaccination (ORV) in West Virginia, USA. Error bars represent 95%
confidence intervals. Figure S6: Histogram of raccoon (n = 2296) ages based on cementum annuli
of premolar teeth from the oral rabies vaccination (ORV) field trials with Ontario Rabies Vaccine
Baits (ONRAB) in West Virginia, USA. The oldest raccoon was 15 years old. Figure S7: Histogram of
skunk (n = 192) ages based on cementum annuli of premolar teeth from the oral rabies vaccination
(ORV) field trials with Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA. The oldest
skunk was 4 years old. Figure S8: Estimated prevalence of the biomarker tetracycline hydrochloride
(TTCC) in raccoon (a) and skunk (b) populations from oral rabies vaccination (ORV) field trials
with Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA in relationship to bait density,
sampling period (pre- or post-ORV), and year. Estimates were from a beta regression analysis and
shading represents the 95% confidence interval. Table S1: Comparison of rabies virus-neutralizing
antibody (RVNA) results for a subset of raccoon and skunk serum samples tested at New York State
Department of Health (NYSDOH; lab 1) and Kansas State University (lab 2). The RVNA titers were
determined from all raccoon and skunk samples at NYSDOH using a cutoff at 0.125 IU/mL. A subset
of 300 raccoon samples and 39 skunk samples were tested at lab 2, which used a cutoff of 0.1 IU/mL.
Table S2: The models compared for the individual-level generalized additive modeling analysis for
the raccoons and skunks. The same models were used for both species and with three different
response variables; which were (1) rabies virus-neutralizing antibodies (RVNA) with a seropositive
cutoff at 0.125 IU/mL, (2) RVNA at 0.5 IU/mL cutoff, and (3) prevalence of the tetracycline biomarker
Within the structure of the models, “*” indicates both an additive and interaction of the variables
surrounding the “*”. Table S3: Information on target species sampling (n), rabies virus-neutralizing
antibody (RVNA) seroprevalence (%) at 0.125 IU/mL cutoff and 95% confidence interval for oral
rabies vaccination with Ontario Rabies Vaccine Baits (ONRAB) at 75 baits/km2 in the period 2012–
2013 and at 300 baits/km2 in the period 2014–2016 in West Virginia, USA. Due to sequential baiting
in the cells for the different bait densities, the year 2014 was split; the pre-ORV trapping period
had previously been baited at 75 baits/km2 and it was only the post-ORV trapping period that
followed baiting at 300 baits/km2. Table S4. Information on target species sampling (n), rabies
virus-neutralizing antibody (RVNA) seroprevalence (%) at the 0.5 IU/mL cutoff and 95% confidence
interval for oral rabies vaccination with Ontario Rabies Vaccine Baits (ONRAB) at 75 baits/km2 in
the period 2012–2013 and at 300 baits/km2 in the period 2014–2016 in West Virginia, USA. Due to
sequential baiting in the cells for the different bait densities, the year 2014 was split; the pre-ORV
trapping period had previously been baited at 75 baits/km2 and it was only the post-ORV trapping
period that followed baiting at 300 baits/km2. All sampled coyotes (n = 1) and foxes (n = 10) were
negative at 0.5 IU/mL and are not included in this table. Table S5: Covariate estimates for generalized
linear mixed model on raccoon and skunk seroprevalence from oral rabies vaccination (ORV) at
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the 0.5 IU/mL cutoff in West Virginia, USA. Table S6: Model selection table of the individual-level
generalized additive modeling candidate model set for raccoon seroprevalence at the 0.125 IU/mL
cutoff. Models are sorted from most parsimonious on top to least parsimonious based on Akaike’s
information criterion corrected (AICc) for small sample sizes. The model names, degrees of freedom
(df), the log likelihood (LL), the AICc, the delta AICc (difference between the model AICc value
and the top model), the model likelihood(ModelLik), the AICc weight (relative support for each
model), and the cumulative AICc weight (Cum.Wt, representing total cumulative weight for the given
model and all models above it) are shown. Table S7: Model selection table of the individual-level
generalized additive modeling candidate model set for skunk seroprevalence at the 0.125 IU/mL
cutoff. Models are sorted from most parsimonious on top to least parsimonious based on Akaike’s
information criterion corrected (AICc) for small sample sizes. The model names, degrees of freedom
(df), the log likelihood (LL), the AICc, the delta AICc (difference between the model AICc value
and the top model), the model likelihood(ModelLik), the AICc weight (relative support for each
model), and the cumulative AICc weight (Cum.Wt, representing total cumulative weight for the
given model and all models above it) are shown. Table S8: Parameters and estimates of the top
competitive models for the individual-level generalized additive modeling for raccoons based on
a rabies virus-neutralizing antibody (RVNA) cutoff of 0.125 IU/mL. Oral rabies vaccination (ORV)
occurred with Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA. Table S9: Parameters
and estimates of the top competitive models for the individual-level generalized additive modeling
for skunks based on a rabies virus-neutralizing antibody (RVNA) cutoff of 0.125 IU/mL. Oral rabies
vaccination (ORV) occurred with Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA.
Table S10: Covariate estimates for generalized linear mixed model on portion of the tetracycline
marked raccoons and skunks from oral rabies vaccination (ORV) in West Virginia, USA. Table S11:
The models compared for the generalized liner mixed model analysis for the raccoons and skunks.
The same models were used for both species and with two different response variables; which were
(1) rabies virus-neutralizing antibodies (RVNA) with a seropositive cutoff at 0.125 IU/mL and (2)
RVNA at 0.5 IU/mL cutoff. Within the structure of the models, “*” indicates both an additive and
interaction of the variables surrounding the “*”. Table S12: Model selection table of the generalized
liner mixed candidate model set for raccoon seroprevalence at the 0.125 IU/mL cutoff. Models
are sorted from most parsimonious on top to least parsimonious based on Akaike’s information
criterion corrected (AICc) for small sample sizes. The model names, number of parameters (k), the
AICc, the delta AICc (difference between the model AICc value and the top model), the model
likelihood(ModelLik), the AICc weight (relative support for each model), the log likelihood (LL), and
the cumulative AICc weight (Cum.Wt, representing total cumulative weight for the given model
and all models above it) are shown. Table S13: Model selection table of the generalized liner mixed
candidate model set for raccoon seroprevalence at the 0.5 IU/mL cutoff. Models are sorted from
most parsimonious on top to least parsimonious based on Akaike’s information criterion corrected
(AICc) for small sample sizes. The model names, number of parameters (k), the AICc, the delta AICc
(difference between the model AICc value and the top model), the model likelihood(ModelLik), the
AICc weight (relative support for each model), the log likelihood (LL), and the cumulative AICc
weight (Cum.Wt, representing total cumulative weight for the given model and all models above it)
are shown. Table S14: Model selection table of the generalized liner mixed candidate model set for
skunk seroprevalence at the 0.125 IU/mL cutoff. Models are sorted from most parsimonious on top
to least parsimonious based on Akaike’s information criterion corrected (AICc) for small sample sizes.
The model names, number of parameters (k), the AICc, the delta AICc (difference between the model
AICc value and the top model), the model likelihood(ModelLik), the AICc weight (relative support
for each model), the log likelihood (LL), and the cumulative AICc weight (Cum.Wt, representing
total cumulative weight for the given model and all models above it) are shown. Table S15: Model
selection table of the generalized liner mixed candidate model set for skunk seroprevalence at the
0.5 IU/mL cutoff. Models are sorted from most parsimonious on top to least parsimonious based on
Akaike’s information criterion corrected (AICc) for small sample sizes. The model names, number
of parameters (k), the AICc, the delta AICc (difference between the model AICc value and the top
model), the model likelihood(ModelLik), the AICc weight (relative support for each model), the log
likelihood (LL), and the cumulative AICc weight (Cum.Wt, representing total cumulative weight
for the given model and all models above it) are shown. Table S16: Model selection table of the
individual-level generalized additive modeling candidate model set for raccoon seroprevalence at
the 0.5 IU/mL cutoff. Models are sorted from most parsimonious on top to least parsimonious based
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on Akaike’s information criterion corrected (AICc) for small sample sizes (AICc). The model names,
degrees of freedom (df), the log likelihood (LL), the AICc, the delta AICc (difference between the
model AICc value and the top model), the model likelihood(ModelLik), the AICc weight (relative
support for each model), and the cumulative AICc weight (Cum.Wt, representing total cumulative
weight for the given model and all models above it) are shown. Table S17: Model selection table of
the individual-level generalized additive modeling candidate model set for skunk seroprevalence at
the 0.5 IU/mL cutoff. Models are sorted from most parsimonious on top to least parsimonious based
on Akaike’s information criterion corrected (AICc) for small sample sizes. The model names, degrees
of freedom (df), the log likelihood (LL), the AICc, the delta AICc (difference between the model AICc
value and the top model), the model likelihood(ModelLik), the AICc weight (relative support for
each model), and the cumulative AICc weight (Cum.Wt, representing total cumulative weight for
the given model and all models above it) are shown. Table S18: Parameters and estimates of the
top competitive models for the individual-level generalized additive modeling for raccoons based
on a rabies virus-neutralizing antibody (RVNA) cutoff at 0.5 IU/mL. Oral rabies vaccination (ORV)
occurred with Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA. Table S19: Parameters
and estimates of the top competitive models for the individual-level generalized additive modeling
for skunks based on a rabies virus-neutralizing antibody (RVNA) cutoff at 0.5 IU/mL. Oral rabies
vaccination (ORV) occurred with Ontario Rabies Vaccine Baits (ONRAB) in West Virginia, USA.
Table S20: Model selection table of the individual-level generalized additive modeling candidate
model set for raccoons based on detection of the tetracycline biomarker. Models are sorted from
most parsimonious on top to least parsimonious based on Akaike’s information criterion (AICc)
corrected for small sample sizes. The model names, degrees of freedom (df), the log likelihood
(LL), the AICc, the delta AICc (difference between the model AICc value and the top model), the
model likelihood(ModelLik), the AICc weight (relative support for each model), and the cumulative
AICc weight (Cum.Wt, representing total cumulative weight for the given model and all models
above it) are shown. Table S21: Model selection table of the individual-level generalized additive
modeling candidate model set for skunks based on detection of the tetracycline biomarker. Models
are sorted from most parsimonious on top to least parsimonious based on Akaike’s information
criterion corrected (AICc) for small sample sizes. The model names, degrees of freedom (df), the
log likelihood (LL), the AICc, the delta AICc (difference between the model AICc value and the top
model), the model likelihood(ModelLik), the AICc weight (relative support for each model), and
the cumulative AICc weight (Cum.Wt, representing total cumulative weight for the given model
and all models above it) are shown. Table S22: Parameters and estimates of the top competitive
models for the individual-level generalized additive modeling for raccoons based on detection of
the tetracycline biomarker. Oral rabies vaccination (ORV) occurred with Ontario Rabies Vaccine
Baits (ONRAB) in West Virginia, USA. Table S23: Parameters and estimates of the top competitive
models for the individual level generalized additive modeling for skunks based on detection of the
tetracycline biomarker. Oral rabies vaccination (ORV) occurred with Ontario Rabies Vaccine Baits
(ONRAB) in West Virginia, USA.
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